Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country

AIM: To investigate peg-interferon (peg-IFN) and ribavirin (RBV) therapy in Myanmar and to predict sustained virologic response (SVR). METHODS: This single-center, open-label, study was conducted in Myanmar between 2009 and 2014. A total of 288 patients infected with HCV genotypes 1, 2, 3 and 6 were...

Descripción completa

Detalles Bibliográficos
Autores principales: Hlaing, Naomi Khaing Than, Banerjee, Debolina, Mitrani, Robert, Arker, Soe Htet, Win, Kyaw San, Tun, Nyan Lin, Thant, Zaw, Win, Khin Maung, Reddy, K Rajender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116605/
https://www.ncbi.nlm.nih.gov/pubmed/27920482
http://dx.doi.org/10.3748/wjg.v22.i43.9613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116605/
https://www.ncbi.nlm.nih.gov/pubmed/27920482
http://dx.doi.org/10.3748/wjg.v22.i43.9613

Ejemplares similares